N,3,3-Trimethylcyclobutan-1-amine hydrochloride

Catalog No. :
ACIETR574
CAS No. :
1803572-39-5
Molecular Formula :
C7H16ClN
Molecular Weight :
149.66

IUPAC Name:N,3,3-Trimethylcyclobutan-1-amine hydrochloride

N,3,3-Trimethylcyclobutan-1-amine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$125.00Login to see priceIn stockInquiry
100mg95%$211.00Login to see priceIn stockIn stock
250mg95%$378.00Login to see priceIn stockIn stock
1g95%$1021.00Login to see priceIn stockIn stock
5g95%$4952.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN,3,3-Trimethylcyclobutan-1-amine hydrochloride
IUPAC NameN,3,3-Trimethylcyclobutan-1-amine hydrochloride
MDL No.MFCD28118665
Molecular FormulaC7H16ClN
Molecular Weight149.66
SMILESCC1(C)CC(NC)C1.[H]Cl
InChI KeyUVZTWUBJBPKEPJ-UHFFFAOYSA-N
SynonymN,3,3-trimethylcyclobutan-1-amine hydrochloride;N,3,3-trimethylcyclobutanamine hydrochloride;N,3,3-trimethylcyclobutan-1-amine hydrochloride - [AC78000]
CAS No.1803572-39-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACIETR574 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLORY498 route compound structure diagram
    ACLORY4981192-33-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIETR574 route product structure diagram
    ACIETR5741803572-39-5 In Stock
Inquiry

2. ACIETR574 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIETR574 route product structure diagram
    ACIETR5741803572-39-5 In Stock
Inquiry

Comments (0)